What happened
Kolmar BioTech updated the terms of convertible bonds to raise US$23.1M, about 91.4% of its market value.
For context, this raise equals about 91.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$23.1M |
| vs. market value | 91.4% |
| Filed | 2026-03-30, [Amended] Material event report (convertible bonds) |
| Source | DART rcept 20260330001505 → open original filing |
Versions of this filing
- 2026-03-03Original
- 2026-03-30Amendment 1 (this page)
Source: DART. Information only, not investment advice.